PACT PHARMA
Pact Pharma is a developer of personalized adoptive T cell therapies designed for the eradication of solid tumors.The company's therapies help in the identification of neo-epitopes that serve as private mutations for each patient's cancer as well as creates an opportunity to engineer autologous T cells that target and kill tumors expressing these neo-antigens, enabling physicians to recognize and remove each patient's cancer cells.
PACT PHARMA
Social Links:
Industry:
Biotechnology Health Care Personal Health Pharmaceutical
Founded:
2016-01-01
Address:
Hayward, California, United States
Country:
United States
Website Url:
http://www.pactpharma.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
200 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Euro IPv6 Google Maps Cloudflare JS CDN JS Amazon SES Next.js Comcast
Similar Organizations
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Invus Opportunities
Invus Opportunities investment in Series C - PACT Pharma
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series C - PACT Pharma
Vida Ventures
Vida Ventures investment in Series C - PACT Pharma
Casdin Capital
Casdin Capital investment in Series C - PACT Pharma
Droia Ventures
Droia Ventures investment in Series C - PACT Pharma
GV
GV investment in Series C - PACT Pharma
Taiho Ventures
Taiho Ventures investment in Series C - PACT Pharma
Zhejiang Canaan Technology
Zhejiang Canaan Technology investment in Series C - PACT Pharma
Foresite Capital
Foresite Capital investment in Series C - PACT Pharma
Wu Capital
Wu Capital investment in Series C - PACT Pharma
Official Site Inspections
http://www.pactpharma.com Semrush global rank: 2.96 M Semrush visits lastest month: 5.5 K
- Host name: any-in-2215.1e100.net
- IP address: 216.239.34.21
- Location: Mexico City Mexico
- Latitude: 19.3421
- Longitude: -99.1927
- Timezone: America/Mexico_City
- Postal: 01090
More informations about "PACT Pharma"
PACT Pharma - Crunchbase Company Profile & Funding
Pact Pharma is a developer of personalized adoptive T cell therapies designed for the eradication of solid tumors.The company's therapies help in the identification of neo-epitopes that serve as …See details»
PACT Pharma Company Overview, Contact Details & Competitors
Learn more about PACT Pharma's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today. ... AmplifyBio, a contract …See details»
PACT Pharma Company Profile | Management and Employees List
PACT Pharma Profile and History. PACT is a clinical-stage biopharmaceutical company pioneering individualized, non-viral precision genome engineered, tumor-specific T cell …See details»
PACT Pharma Company Profile 2024: Valuation, …
PACT Pharma was founded in 2016. Where is PACT Pharma headquartered? PACT Pharma is headquartered in South San Francisco, CA. What is the size of PACT Pharma? PACT Pharma has 134 total employees. What industry is …See details»
PACT Pharma - LinkedIn
PACT Pharma | 4,912 followers on LinkedIn. PACT Pharma is a privately held biotechnology company developing personalized T cell therapies for cancer | At PACT Pharma, our vision is …See details»
PACT Pharma Overview | SignalHire Company Profile
The position of the CEO is occupied by Scott Garland. Its headquarters is located at South San Francisco, California, USA. The number of employees ranges from 100 to 250. The annual …See details»
PACT Pharma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore PACT Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 29 news, and 25 literature, Disease Domain:Neoplasms ...See details»
PACT Pharma - Craft
PACT Pharma has 5 employees at their 1 location and $200 m in total funding,. See insights on PACT Pharma including office locations, competitors, revenue, financials, executives, …See details»
Home | PACT Pharma, Inc.
The ground-breaking technology in development at PACT Pharma aims to re-program one’s own immune system to target and to eradicate the cancer. This is the exciting promise of …See details»
PACT Pharma - VentureRadar
Find out more about PACT Pharma, Biotechnology, Biotech, AI, T-Cells and Stem Cells and Cellular Therapy and . All; Ranked; Organisation Names; Apps and Links. Homepage (myVR) …See details»
PACT Pharma Information - RocketReach
At PACT Pharma, our vision is to create potentially curative T cell therapies for solid cancers that are tailored for each and every patient. We are pioneering non-viral, precision-genome …See details»
PACT Pharma Company Profile - Selligence
Pact Pharma is a developer of personalized adoptive T cell therapies designed for the eradication of solid tumors.The company's therapies help in the identification of neo-epitopes that serve as …See details»
Team | PACT Pharma, Inc.
[email protected]. Our Team. Team; Senior Management; Scientific Advisory Board; PACT Board of Directors; Investors; Personalized Medicine. Immuno-oncology: Neo-Antigens in …See details»
PACT Pharma - Org Chart, Teams, Culture & Jobs - The Org
View PACT Pharma's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
PACT Pharma - Contacts, Employees, Board Members, Advisors
Organization. PACT Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Member and Advisor Profiles 7. Contacts …See details»
AmplifyBio Acquires PACT Pharma Assets | AmplifyBio
Oct 3, 2022 AmplifyBio was spun out in 2021 from Battelle, a not-for-profit organization that advances science and technology to have the greatest impact on our society and economy. …See details»
PACT Pharma’s Competitors, Revenue, Number of Employees
PACT Pharma’s Profile, Revenue and Employees. PACT Pharma is a California-based clinical-stage biopharmaceutical company that develops T-cell therapies to treat patients with solid …See details»
Cellares Adds PACT Pharma to its Early Access Partnership Program
Jan 8, 2021 PACT Pharma is the second collaborator and first industry organization to join its EAPP, following Fred Hutchinson Cancer Research Center. Under the terms of the …See details»
PACT Pharma Announces Agreement to Sell Select Assets to …
Oct 3, 2022 PACT Pharma Atulya R. Agarwal [email protected] Vida Strategic Partners (on behalf of PACT Pharma) Tim Brons (Media) 415-675-7402 [email protected] Amplify-Bio …See details»
AMPLIFYBIO ACQUIRES PACT PHARMA ASSETS TO ENHANCE …
Oct 3, 2022 AmplifyBio was spun out in 2021 from Battelle, a not-for-profit organization that advances science and technology to have the greatest impact on our society and economy.See details»